Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
Impact in
- Cancer Research 151
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm843 →Countries where authors are citing Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
This map shows the geographic impact of Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning more than expected).
Fields of papers citing Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
This network shows the impact of Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.
About Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
This paper, published in 2003, received 677 indexed citations . Written by Lun‐Xiu Qin, Marshonna Forgues, Ping He, Jin-Woo Kim, A Peng, Richard H. Simon, Li Y, Ana I. Robles, Yidong Chen and Zeng‐Chen Ma covering the research area of Molecular Biology, Rheumatology and Biotechnology. It is primarily cited by scholars working on Molecular Biology (282 citations), Cancer Research (151 citations), Hepatology (127 citations), Oncology (118 citations) and Rheumatology (100 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm843.